Followers | 60 |
Posts | 5252 |
Boards Moderated | 1 |
Alias Born | 11/10/2009 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, April 28, 2014 8:39:35 AM
1.) and most crucial…is that no one took the bait on the "new drug" PR to move the PPS at all…so after a solid month or two, MCIC needed to go to the next step……the announcement alone did not provide any interest in the stock or budge the PPS
2. development sector is not impressed with the drugs target market……..not a lucrative segment for profitability... the medical world "skins the migraine cat" in 3 or 4 ways, all of which produce mediocre to sufficient results,
3.) this Migraine patent has ALREADY proven itself NOT TO BE the "magic bullet"……. takes MUCH MORE capability than MCIC possesses to FUND and MARKET such a drug… its not worth the COST need to bring to market…not worth developing….name the last successful drug to be FOUND and developed OUTSIDE of MEDIUM to BIG pharma..(which MCIC is neither a part of )…………..sorta tells ya MCIC is just fishin' the concept to see who "bites"
where have you seen that before????????????
FEATURED Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM